Zusammenfassung
Benzodiazepine gehören zu den in der Medizin häufig verordneten Medikamenten. Es ist Müller-Oerlinghausen (1992) beizupflichten, der auf den fahrlässigen Gebrauch von Arzneimittelverbrauchsdaten hinweist. Auch wenn Sedativa-/Hypnotikaverordnungen im Vergleich zu anderen Medikamentengruppen an 14. Stelle der verordnungsstärksten Indikationsgruppen gehören (Schwabe u. Paffrath 1990, zit. in Müller-Oerlinghausen 1992), ist gleichzeitig festzuhalten, daß die Anzahl der Verordnungen von Benzodiazepinen, insbesondere bezüglich ihres Einsatzes als Tagessedativa, ständig abgenommen hat.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
Ashton H (1984) Benzodiazepine withdrawal:a unfinished story. Br Med J 288:1135–1140
Ashton H (1991) Protracted withdrawal syndromes for benzodiazepines
Brenner PM, Wolf B, Grohmann R, Rüther E (1988) Benzodiazepine dependence:aetiological factors, time course, consequences and withdrawal symptomatology:a stody of five cases. Drug Alc Depend 22:253–261
Busto U, Fornazzari L, Naranjo CA (1988) Protracted tinnitus after discontinuation of long-term therapeutic use of benzodiazepines. J Clin Psychopharmacol 8:359–362
Carranza J (1980) Long-term use and abuse of benzodiapezines. Pharmacopsychiat Neuropsychopharmakol 13:25 4–25 8
Ciraulo DA, Barnhill JG, Ciraulo AM, Greenblatt DJ, Shader RI (1989) Parental alcoholism as a risk factor in benzodiazepine abuse:a pilot study. Am J Psychiat 146:1333–1335
Crouch G, Robson M, Hallstrom C (1988) Benzodiazepine dependent patients and their psychological treatment. Prog Neuropsychopharmacol Biol Psychiat 12:503–510
De Wit H, Uhlenhuth EH, Hedeker D, Mc Cracken SC, Johanson CE (1986) Lack of preference for diazepam in anxious volunteers. Arch Gen Psychiat 43:533–541
Dickmann U, Poser W, Poser S (1988) Long term outcome of benzodiazepine dependence. Psychopharmacology [Suppl] 96:307–312
Dilling H, Mombom W, Schmidt MH (1991) ICD-10. Huber, Bern
Funderburk FR, Griffiths RR, Mc Leod DR, Bigelow GE, Mackenzie A, Liebson IA, Nemeth Cosleit R (1988) Relative abuse liability of lorazepam and diazepam:an evaluation in “recreational” drug users. Drug Depend 22:215–222
Golombok S, Higgitt A, Fonagy P, Dodds S, Saper J, Lader M (1987) A follow-up study of patients treated for benzodiazepine dependence. Br J Med Psychol 60:141–149
Hallstroem C, Crough G, Robson M, Shine P (1988) The treatment of tranquillizer dependence propanolol. Postgrad Med J [Suppl] 64:40–44
Hartog J, Tusel DJ (1987) Valium use and abuse by methadone maintenance clients. Int J Addict 22:1147–1154
Higgitt AC, Golombok S, Fonagy P, Lader MH (1987) Group treatment of benzodiazepine dependence. Br J Addict 82:517–532
Ladewig D (1992) Abusus und Abhängigkeit. In:Riederer P, Laux G, Plödinger W (Hrsg) Neuropsychopharmaka, Bd. 1. Springer, Wien New York, S 411–419
Ladewig D. Grossenbacher H (1988) Benzodiazepine abuse in patients of doctors in domiciliary practice in the Basel area. Pharmacopsychiatry 21:104–108
Merz WA (1982) Standardized assessment of the symptoms of the benzodiazepine withdrawal syndrome prior to during and after treatment of anxiety with a benzodiazepine by means of a novel selfrating scale. In:Abstr 13th Collegium Int Neuropsychopharmacol Congr, Jerusalem
Merz WA (1933) Modular data base and program system for the automatic generation of CRFs for clinical trials:psychiatric indications. Beltz, Weinheim
Merz WA, Bullmer V (1983) Symptoms of the barbiturate/benzodiapenine withdrawal syndrome in healthy volunteers:standardized assessment by a newly developed self-rating scale. J Psychoactive Drugs 15:71–84
Müller-Oerlinghausen B (1992) Pharmakoepidemiologie psychotroper Substanzen. In:Riederer P, Laux G, Pöldinger W (Hrsg) Neuropsychopharmaka, Bd 1. Springer, Wien New York, S 323–325
Pecknold JC, McClure DJ, Fleuri D, Chang H (1982) Benzodiazepine withdrawal effects. Prog Neuropsychopharmacol Biol Psychiat 6:517–522
Petursson H, Lader MH (1986) Dependence on tranquilizers. Oxford Univ Press, London
Poser W, Rüther E (1991) Benzodiazepine, eine Standortbestimmung. MMV-Medizin- Verlag, München
Renfordt E, Wirtz W (1984) Withdrawal syndromes. Treatment of benzodiazepine dependence with baclofen. MMW 126:1214–1215
Rickels K, Schweizer E, Case GW (1988) Risk factors in benzodiazepine misuse and dependence, benzodiazepine dependence, withdrawal severity and clinical outcome:effects of personality. Psychopharmacol Bull 24:415–420
Robson M, Crouch G, Hallstrom C (1986) Psychological treatment for benzodiazepine dependence. J R Coll Gen Practitioners 36:1–9
Smith DE, Wesson DR (1985) The benzodiazepines. In:Current standards for medical practice. MTP Press, Lancaster
Stitzer ML, Griffiths RR, McLellan AT, Grabowski J, Hawthrone JW (1981) Diaze¬pam use among methadone maintenance patients:patterns and dosages. Drug Alc Depend 8:189–199
Tennant FS Jr, Pumphrey EA (1984) Benzodiazepine dependence of several years duration:clinical profile and therapeutic benefits. Natl Inst Drug Abuse Res Monogr Set 55:211–216
Tyrer P, Murphy S, Riley P (1988) The benzodiazepine withdrawal symptom questionnaire. J Affect Disorders 19:53–61
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Ladewig, D. (1994). Das Benzodiazepinentzugssyndrom — Skalierungen und medikamentöse Strategien. In: Tretter, F., Bussello-Spieth, S., Bender, W. (eds) Therapie von Entzugssyndromen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-78778-2_12
Download citation
DOI: https://doi.org/10.1007/978-3-642-78778-2_12
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-57638-9
Online ISBN: 978-3-642-78778-2
eBook Packages: Springer Book Archive